Cargando…

The Added Value of Diagnostic and Theranostic PET Imaging for the Treatment of CNS Tumors

This review highlights the added value of PET imaging in Central Nervous System (CNS) tumors, which is a tool that has rapidly evolved from a merely diagnostic setting to multimodal molecular diagnostics and the guidance of targeted therapy. PET is the method of choice for studying target expression...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pruis, Ilanah J., van Dongen, Guus A. M. S., Veldhuijzen van Zanten, Sophie E. M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7037158/ https://www.ncbi.nlm.nih.gov/pubmed/32033160 http://dx.doi.org/10.3390/ijms21031029

Ejemplares similares

FAPI PET versus FDG PET, CT or MRI for Staging Pancreatic-, Gastric- and Cholangiocarcinoma: Systematic Review and Head-to-Head Comparisons of Diagnostic Performances
por: Veldhuijzen van Zanten, Sophie E. M., et al.
Publicado: (2022)

Reproducibility of APT-weighted CEST-MRI at 3T in healthy brain and tumor across sessions and scanners
por: Wu, Yulun, et al.
Publicado: (2023)

PET imaging with radiolabeled antibodies and tyrosine kinase inhibitors: immuno-PET and TKI-PET
por: van Dongen, Guus A. M. S., et al.
Publicado: (2012)

THU090 18F-FET PET-MRI; A Novel And Improved Technique For Detection Of Small Functional Pituitaryadenomas
por: Pruis, Ilanah, et al.
Publicado: (2023)

Transitioning to molecular diagnostics in pediatric high-grade glioma: experiences with the 2016 WHO classification of CNS tumors
por: Baugh, Joshua N, et al.
Publicado: (2021)

Noninvasive differentiation of molecular subtypes of adult nonenhancing glioma using MRI perfusion and diffusion parameters
por: Pruis, Ilanah J, et al.
Publicado: (2022)

Positive [(18)F]fluoroethyltyrosine PET/MRI in suspected recurrence of growth hormone–producing pituitary adenoma in a paediatric patient
por: Veldhuijzen van Zanten, Sophie E. M., et al.
Publicado: (2021)

Applications of Theranostics for Detecting and Targeting CNS Injuries and Diseases
por: Sun, Yu-Yo, et al.
Publicado: (2022)

Added value of amyloid PET in individualized risk predictions for MCI patients
por: van Maurik, Ingrid S., et al.
Publicado: (2019)

(18) F-FDG PET standard uptake values of the normal pons in children: establishing a reference value for diffuse intrinsic pontine glioma
por: Jansen, Marc H A, et al.
Publicado: (2014)

On the Added Value of Baseline FDG-PET in Malignant Lymphoma
por: Quarles van Ufford, Henriette, et al.
Publicado: (2009)

GRPR versus PSMA: expression profiles during prostate cancer progression demonstrate the added value of GRPR-targeting theranostic approaches
por: Verhoeven, Marjolein, et al.
Publicado: (2023)

State of the Art in Radiolabeling of Antibodies with Common and Uncommon Radiometals for Preclinical and Clinical Immuno-PET
por: Chomet, Marion, et al.
Publicado: (2021)

PSMA PET Imaging in Glioblastoma: A Preclinical Evaluation and Theranostic Outlook
por: Kirchner, Maximilian A., et al.
Publicado: (2021)

Functionalization of theranostic AGuIX® nanoparticles for PET/MRI/optical imaging
por: Thakare, Vivek, et al.
Publicado: (2019)

Immuno-PET for Clinical Theranostic Approaches
por: Bailly, Clément, et al.
Publicado: (2016)

IMG-04. POTENTIAL TARGETS FOR THERANOSTICS IN PEDIATRIC HIGH-GRADE CENTRAL NERVOUS SYSTEM (CNS) TUMORS
por: Plasschaert, Sabine, et al.
Publicado: (2023)

Added Diagnostic Value of (11)C-PiB-PET in Memory Clinic Patients with Uncertain Diagnosis
por: Frederiksen, K.S., et al.
Publicado: (2012)

Repeated Witnessing of Conspecifics in Pain: Effects on Emotional Contagion
por: Carrillo, Maria, et al.
Publicado: (2015)

Performance of nanoScan PET/CT and PET/MR for quantitative imaging of (18)F and (89)Zr as compared with ex vivo biodistribution in tumor-bearing mice
por: Chomet, Marion, et al.
Publicado: (2021)

Production and in vivo PET/CT imaging of the theranostic pair (132/135)La
por: Aluicio-Sarduy, Eduardo, et al.
Publicado: (2019)

Clinical Results in Medullary Thyroid Carcinoma Suggest High Potential of Pretargeted Immuno-PET for Tumor Imaging and Theranostic Approaches
por: Bodet-Milin, Caroline, et al.
Publicado: (2019)

Immuno-PET Imaging of Atherosclerotic Plaques with [(89)Zr]Zr-Anti-CD40 mAb—Proof of Concept
por: Poels, Kikkie, et al.
Publicado: (2022)

Pediatric high-grade gliomas and the WHO CNS Tumor Classification—Perspectives of pediatric neuro-oncologists and neuropathologists in light of recent updates
por: Gielen, Gerrit H, et al.
Publicado: (2022)

The Incremental Added Value of Including the Head in (18)F-FDG PET/CT Imaging for Cancer Patients
por: Abdelmalik, Amir G., et al.
Publicado: (2013)

The Clinical Assessment of MicroRNA Diagnostic, Prognostic, and Theranostic Value in Colorectal Cancer
por: Al-Akhrass, Hussein, et al.
Publicado: (2021)

Prediction of Subtle Cognitive Decline in Normal Aging: Added Value of Quantitative MRI and PET Imaging
por: Giannakopoulos, Panteleimon, et al.
Publicado: (2021)

Development of a PET radioligand for potassium channels to image CNS demyelination
por: Brugarolas, Pedro, et al.
Publicado: (2018)

Adding Value to Liquid Biopsy for Brain Tumors: The Role of Imaging
por: Khalili, Nastaran, et al.
Publicado: (2023)

(89)Zr-cetuximab PET imaging in patients with advanced colorectal cancer
por: Menke-van der Houven van Oordt, Catharina Willemien, et al.
Publicado: (2015)

Added value of CRP to clinical features when assessing appendicitis in children
por: Blok, Guus C. G. H., et al.
Publicado: (2022)

Editorial: Advances in theranostics of CNS injuries and diseases: from basic research to clinical practice
por: Li, Bo, et al.
Publicado: (2023)

Transforming a Targeted Porphyrin Theranostic Agent into a PET Imaging Probe for Cancer
por: Shi, Jiyun, et al.
Publicado: (2011)

Evaluation of (134)Ce/(134)La as a PET Imaging Theranostic Pair for (225)Ac α-Radiotherapeutics
por: Bobba, Kondapa Naidu, et al.
Publicado: (2023)

PET Imaging of Liposomal Glucocorticoids using (89)Zr-oxine: Theranostic Applications in Inflammatory Arthritis
por: Gawne, Peter J., et al.
Publicado: (2020)

p-Isothiocyanatobenzyl-desferrioxamine: a new bifunctional chelate for facile radiolabeling of monoclonal antibodies with zirconium-89 for immuno-PET imaging
por: Perk, Lars R., et al.
Publicado: (2009)

Noise sensitivity of (89)Zr-Immuno-PET radiomics based on count-reduced clinical images
por: Somasundaram, Ananthi, et al.
Publicado: (2022)

Intracranial hemangiopericytoma showing excellent uptake on arterial injection of [(68)Ga]DOTATATE
por: Veldhuijzen van Zanten, Sophie E. M., et al.
Publicado: (2020)

Carotid intima-media thickness and endothelial function: useful surrogate markers for establishing cardiovascular risk in patients with inflammatory rheumatic disease – authors' response
por: van Zanten, Jet JCS Veldhuijzen, et al.
Publicado: (2008)

Inflammation, carotid intima-media thickness and atherosclerosis in rheumatoid arthritis
por: Veldhuijzen van Zanten, Jet JCS, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_cofjr28m5t43k6pgl10d22abql